Medicine
fromTNW | China
3 days agoBristol Myers Squibb signs $15.2 billion drug deal with China's Hengrui as patent cliff looms
Bristol Myers Squibb will license 13 early-stage drug programmes from Hengrui in a deal up to $15.2 billion to offset a looming patent cliff.